Characteristics of workers' compensation claim applications for COVID-19 infections in South Korea.


Journal

Industrial health
ISSN: 1880-8026
Titre abrégé: Ind Health
Pays: Japan
ID NLM: 2985065R

Informations de publication

Date de publication:
01 Feb 2023
Historique:
pubmed: 18 2 2022
medline: 4 2 2023
entrez: 17 2 2022
Statut: ppublish

Résumé

This study aimed to identify the major industries and jobs with the highest proportion of workers' compensation (WC) claims for COVID-19, characterize COVID-19 WC claims in terms of their demographic properties and disease severity, and identify factors influencing the approval of COVID-19 WC claims as occupational disease. A total of 488 workers who submitted COVID-19-related claims to the Korea Workers' Compensation and Welfare Service (KWCWS) from January 2020 to July 2021 were analyzed. A Fisher's exact test was employed to associate the severity of COVID-19 infection with demographic properties. The highest proportion of all COVID-19 WC claims compensated as occupational disease (N=462) were submitted by healthcare workers (HCW=233, 50%), while only 9% (N=41) of the total originated from manufacturing industries. The 5% (N=26) of the COVID-19 WC claims accepted were evaluated as severe (N=15) and acute respiratory distress syndrome (N=9). A total of 71% (N=329) of the COVID-19 patients compensated (N=462) were from workplaces with infection clusters. A total of 26 WC cases were rejected for various reasons, including unclear infection routes, infection at private gatherings (including within families), no diagnosis, and more. Given our findings, we suggest an official system should be established to detect and compensate more job-associated infectious diseases like COVID-19.

Identifiants

pubmed: 35173135
doi: 10.2486/indhealth.2021-0271
pmc: PMC9902263
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-87

Références

Int J Environ Res Public Health. 2020 Jul 07;17(13):
pubmed: 32645826
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
J Law Med. 2021 Mar;28(2):546-566
pubmed: 33768758
Saf Health Work. 2021 Dec;12(4):530-535
pubmed: 34462672
J Occup Environ Med. 2021 May 1;63(5):374-380
pubmed: 33395171
JAMA Intern Med. 2020 Jun 1;180(6):817-818
pubmed: 32275292
Lancet Infect Dis. 2020 Dec;20(12):1401-1408
pubmed: 32758438
Int J Environ Res Public Health. 2020 May 02;17(9):
pubmed: 32370116
Saf Health Work. 2019 Sep;10(3):347-354
pubmed: 31497332
Med Lav. 2021 Jun 15;112(3):219-228
pubmed: 34142674
Occup Environ Med. 2020 Dec;77(12):818-821
pubmed: 32967988
Policy Polit Nurs Pract. 2020 Aug;21(3):174-186
pubmed: 32635838

Auteurs

Min-Woo Nam (MW)

Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Republic of Korea.

Jinjoo Chung (J)

Korea Workers' Compensation & Welfare Service, Republic of Korea.

Soyoung Park (S)

Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Republic of Korea.

Woncheol Lee (W)

Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Republic of Korea.

Jihoon Park (J)

Joint Inter-agency Chemical Emergency Preparedness Center of Ulsan, Nakdong River Basin Environmental Office, Ministry of Environment, Republic of Korea.

Dong-Hee Koh (DH)

Department of Occupational and Environmental Medicine, International St. Mary's Hospital, Catholic Kwandong University, Republic of Korea.

Sangjun Choi (S)

Graduate School of Public Health and Healthcare Management, The Catholic University of Korea, Seoul, Republic of Korea.

Ju-Hyun Park (JH)

Department of Statistics, Dongguk University, Republic of Korea.

Dong-Uk Park (DU)

Department of Environmental Health, Korea National Open University, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH